Home › Funds › OAKTREE CAPITAL MANAGEMENT LP › TDOC

OAKTREE CAPITAL MANAGEMENT LP position in TDOC

TELADOC HEALTH INC · Health Care

OAKTREE CAPITAL MANAGEMENT LP reported holding 53,624,000 shares of TDOC (TELADOC HEALTH INC) in its Q2 2026 13F filing — a position valued at US$52.3M, representing 0.76% of its reported portfolio and ranking #33 among its reported holdings. OAKTREE CAPITAL MANAGEMENT LP has disclosed TDOC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)53.62M sh
Reported value held$52.26M
Portfolio Weight0.76%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How OAKTREE CAPITAL MANAGEMENT LP's TDOC position evolved

OAKTREE CAPITAL MANAGEMENT LP first disclosed a stake in TDOC in Q3 2023 at 6,900,000 shares (US$5.5M). The position peaked in Q2 2026 at 53,624,000 shares, worth US$52.3M. Across 12 filings, OAKTREE CAPITAL MANAGEMENT LP increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 53,624,000 shares valued at US$52.3M — an increase of 20,554,000 shares quarter over quarter.. Notable position changes include a 106% increase in Q4 2023 (shares fell 30% over the following quarter), a 69% trim in Q1 2025 (shares rose 9% over the following quarter), a 1209% increase in Q2 2025 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.90M $5.53M New
Q4 2023 14.21M $11.75M Add
Q1 2024 9.14M $7.72M Reduce
Q2 2024 9.44M $7.84M Add
Q3 2024 6.67M $5.79M Reduce
Q4 2024 7.57M $6.65M Add
Q1 2025 2.32M $2.30M Reduce
Q2 2025 30.34M $28.06M Add
Q3 2025 40.64M $38.16M Add
Q4 2025 38.48M $36.75M Reduce
Q1 2026 33.07M $31.71M Reduce
Q2 2026 53.62M $52.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TDOC and 13F data

TDOC (TELADOC HEALTH INC) is a Health Care company. 24 other funds we track also report a position in TDOC — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$181.3M), Context Capital Management, LLC (US$102.8M), ARISTEIA CAPITAL, L.L.C. (US$75.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TDOC

All TDOC fund holders →

FAQ

How long has OAKTREE CAPITAL MANAGEMENT LP held TDOC?

OAKTREE CAPITAL MANAGEMENT LP has disclosed TDOC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is OAKTREE CAPITAL MANAGEMENT LP's current position in TDOC?

As of Q2 2026, OAKTREE CAPITAL MANAGEMENT LP holds 53.62M shares of TDOC (TELADOC HEALTH INC), valued at $52.26M, representing 0.76% of its reported portfolio and ranking #33.

Has OAKTREE CAPITAL MANAGEMENT LP been buying or selling TDOC?

In the latest 13F filing (Q2 2026), OAKTREE CAPITAL MANAGEMENT LP increased its position in TDOC. The position peaked in Q2 2026 at 53.62M shares.

Which other funds hold TDOC?

Other major institutional holders of TDOC include TENOR CAPITAL MANAGEMENT Co., L.P., Context Capital Management, LLC, ARISTEIA CAPITAL, L.L.C., among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.